Loading...

Nuveen Churchill Direct Lending Corp.

NCDLNYSE
Financial ServicesAsset Management
$16.16
$0.07(0.47%)

Nuveen Churchill Direct Lending Corp. (NCDL) Stock Overview

Explore Nuveen Churchill Direct Lending Corp.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
45.67%
45.67%
Profit Growth
$2.18
53.18%
EPS Growth
$2.18
5.29%
Operating Margin
-139.90%
58.97%
ROE
11.76%
53.18%
Dividend Yield
0.00%
7.03%

Analyst Recommendations

Strong Buy
Buy
Hold
Sell
Strong Sell

Price Targets

Low$19.00
Average$19.00
High$19.00

Company Profile

Nuveen Churchill Direct Lending Corp. (the “Company”) is business development company and was formed on March 13, 2018, as a limited liability company under the laws of the State of Delaware and was converted into a Maryland corporation on June 18, 2019 prior to the commencement of operations. The Company is a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). The Company's investment objective is to generate attractive risk-adjusted returns primarily through current income by investing primarily in senior secured loans to private equity-owned U.S. middle market companies, which the Company defines as companies with approximately $10.0 million to $100.0 million of earnings before interest, taxes, depreciation and amortization (“EBITDA”). The Company will focus on privately originated debt to performing U.S. middle market companies, with a portfolio expected to comprise primarily of first-lien senior secured debt and unitranche loans (other than last-out positions in unitranche loans) (collectively “Senior Loans”). The Company will also opportunistically invest in junior capital opportunities (second-lien loans, subordinated debt, last-out positions in unitranche loans and equity-related securities) (collectively “Junior Capital Investments”).

CEO

Mr. Kenneth John Kencel J.D.

Headquarters

375 Park Avenue, New York City, MD

Founded

2024

Frequently Asked Questions